Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
CJC-1295 (no DAC) is often studied in combination with other secretagogues like Ipamorelin for potential synergistic effects
A 43-amino acid synthetic peptide modeled after thymosin beta-4.- Reported to regulate actin dynamics via its LKKTETQ sequence, thereby influencing cellular migration and motility.- May also elevate microRNA-146a, which suppresses inflammatory pathways involving IRAK1 and TRAF6.- Preclinical studies point toward roles in wound contraction, tissue vascularization, and cardiac resilience under stress
PLOS Pathog 20:e1012270
It depends on the cause
Effects of incretin-based therapy on CV complications In line with previous evidence accrued in patients with T2D 83 , recent data demonstrated for the first time that incretin-based therapy was associated with CV risk reduction in patients with overweight or obesity with normoglycemia or prediabetes
US$ 28.29
US$ 20.41
US$ 24.38
